Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M503113200 on August 9, 2005

J. Biol. Chem., Vol. 280, Issue 40, 33811-33818, October 7, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/40/33811    most recent
M503113200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jiang, S. X.
Right arrow Articles by Preston, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jiang, S. X.
Right arrow Articles by Preston, E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Chlortetracycline and Demeclocycline Inhibit Calpains and Protect Mouse Neurons against Glutamate Toxicity and Cerebral Ischemia*

Susan X. Jiang{ddagger}, Jittiwud Lertvorachon§, Sheng T. Hou{ddagger}1, Yasuo Konishi§, Jacqueline Webster{ddagger}, Geoff Mealing{ddagger}, Eric Brunette{ddagger}, Joseph Tauskela{ddagger}, and Edward Preston{ddagger}

From the {ddagger}Neurophysiology Group, National Research Council Institute for Biological Sciences, National Research Council Canada, Ottawa, Ontario K1A 0R6, Canada and the §Chemical Biology Group, National Research Council Biotechnology Research Institute, National Research Council Canada, Montreal, Quebec H4P 2R2, Canada

Minocycline is a potent neuroprotective tetracycline in animal models of cerebral ischemia. We examined the protective properties of chlortetracycline (CTC) and demeclocycline (DMC) and showed that these two tetracyclines were also potent neuroprotective against glutamate-induced neuronal death in vitro and cerebral ischemia in vivo. However, CTC and DMC appeared to confer neuroprotection through a unique mechanism compared with minocycline. Rather than inhibiting microglial activation and caspase, CTC and DMC suppressed calpain activities. In addition, CTC and DMC only weakly antagonized N-methyl-D-aspartate (NMDA) receptor activities causing 16 and 14%, respectively, inhibition of NMDA-induced whole cell currents and partially blocked NMDA-induced Ca2+ influx, commonly regarded as the major trigger of neuronal death. In vitro and in vivo experiments demonstrated that the two compounds selectively inhibited the activities of calpain I and II activated following glutamate treatment and cerebral ischemia. In contrast, minocycline did not significantly inhibit calpain activity. Taken together, these results suggested that CTC and DMC provide neuroprotection through suppression of a rise in intracellular Ca2+ and inhibition of calpains.


Received for publication, March 21, 2005 , and in revised form, July 26, 2005.

* This work was supported in part by research grants from the Genomics and Health Initiatives of National Research Council and Heart and Stroke Foundation of Ontario Grant-in-aid NA5393 (to S. T. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: Neurophysiology Group, NRC Inst. for Biological Sciences, National Research Council Canada, 1200 Montreal Rd., Bldg. M54, Ottawa, ON, K1A 0R6, Canada. Tel.: 613-993-7764; Fax: 613-941-7764; E-mail: sheng.hou{at}nrc-cnrc.gc.ca.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
NeurologyHome page
A. Omar and L. N. Johnson
Tetracycline delays ocular motility decline in chronic progressive external ophthalmoplegia
Neurology, April 3, 2007; 68(14): 1159 - 1160.
[Full Text] [PDF]


Home page
IOVSHome page
D. W. Leung, L. A. Lindlief, A. Laabich, G. P. Vissvesvaran, M. Kamat, K. L. Lieu, A. Fawzi, and R. Kubota
Minocycline Protects Photoreceptors from Light and Oxidative Stress in Primary Bovine Retinal Cell Culture
Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 412 - 421.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. C. Alano, T. M. Kauppinen, A. V. Valls, and R. A. Swanson
Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations
PNAS, June 20, 2006; 103(25): 9685 - 9690.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. T. Hou, S. X. Jiang, A. Desbois, D. Huang, J. Kelly, L. Tessier, L. Karchewski, and J. Kappler
Calpain-cleaved collapsin response mediator protein-3 induces neuronal death after glutamate toxicity and cerebral ischemia.
J. Neurosci., February 22, 2006; 26(8): 2241 - 2249.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement